Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook

EarningsPositive

AI Analysis

Summary

Novo Nordisk reported adjusted operating profit of DKK 33,389 million for Q2 2026 and raised its full-year outlook. The company announced H1 2026 financial results on August 4, 2026.

Financial Highlights

Guidance

raised full-year outlook

Importance:5/10

Sentiment:

0.60

earningsQ2_2026financial_resultsguidance_raise

Related Companies

$NVO

Read the original article

Published by GlobeNewswire Pharma on August 4, 2026 4:37 PM

Read Original